Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Curr Protoc. 2021 Mar;1(3):e92. doi: 10.1002/cpz1.92.
This article describes the purification of HLA-bound peptides and their subsequent sequencing by mass spectrometry. These methods can be used for both HLA class I and class II molecules and can be adapted to different species depending on the availability of specific antibodies. Peptides can be successfully isolated from a variety of sample types, including in vitro cultured cells and primary tissues. The method involves the affinity capture of HLA-peptide complexes and separation of peptides from HLA heavy chains, followed by tailored interrogation by mass spectrometry to take into account the non-tryptic nature of endogenously derived HLA-bound peptides. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Preparation of immunoaffinity column Alternate Protocol 1: Preparation of microscale immunoaffinity column Basic Protocol 2: Generation of cell lysate and HLA immunoaffinity purification Alternate Protocol 2: Microscale immunoaffinity purification Basic Protocol 3: Separation of HLA peptides by reverse-phase high-performance liquid chromatography (RP-HPLC) Alternate Protocol 3: Isolation of HLA peptides using molecular weight cutoff (MWCO) filter Basic Protocol 4: Mass spectrometry and data analysis.
本文描述了 HLA 结合肽的纯化及其随后通过质谱进行测序。这些方法可用于 HLA Ⅰ类和Ⅱ类分子,并且可以根据特定抗体的可用性适应不同的物种。肽可以成功地从各种类型的样品中分离出来,包括体外培养的细胞和原代组织。该方法涉及 HLA-肽复合物的亲和捕获以及肽与 HLA 重链的分离,然后通过质谱进行定制化分析,以考虑内源性 HLA 结合肽的非胰蛋白酶性质。© 2021 Wiley Periodicals LLC. 基本方案 1:免疫亲和柱的制备 可选方案 1:微尺度免疫亲和柱的制备 基本方案 2:细胞裂解物的产生和 HLA 免疫亲和纯化 可选方案 2:微尺度免疫亲和纯化 基本方案 3:反相高效液相色谱 (RP-HPLC) 分离 HLA 肽 可选方案 3:使用分子量截止 (MWCO) 过滤器分离 HLA 肽 基本方案 4:质谱和数据分析。